PACB logo

Pacific Biosciences Of California (PACB) Net Income

Annual Net Income

-$306.74 M
+$7.51 M+2.39%

31 December 2023

1-Year Change

+2.39%
PACB annual net profit is up +2.39% year-on-year

3-Year Change

-1143.21%
PACB annual net profit is down -1143.21% over the past 3 years

All-time High

$29.40 M
PACB annual net profit is currently -1143.21% below its historical high of $29.40 million

Sector Rank

5.14%
PACB annual net profit is higher than 5.14% of companies in Healthcare sector

Annual Net Income Formula

Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
Annual Net Margin-152.97%
PACB annual net profit margin is -152.97%
Annual Revenue$200.52 M
PACB annual revenue is $200.52 million
Annual EPS-$1.21
PACB annual earnings per share is -$1.21

PACB Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$60.73 M
+$112.59 M+64.96%

30 September 2024

1-Year Change

+9.19%
PACB quarterly net profit is up +9.19% year-on-year

3-Year Change

-467.1%
PACB quarterly net profit is down -467.1% over the past 3 years

All-time High

$74.94 M
PACB quarterly net profit is currently -181.04% below its historical high of $74.94 million

Sector Rank

7.1%
PACB quarterly net profit is higher than 7.1% of companies in Healthcare sector
Quarterly Net Margin-151.94%
PACB quarterly net profit margin is -151.94%
Quarterly Revenue$39.97 M
PACB quarterly revenue is $39.97 million
Quarterly Gross Profit$10.00 M
PACB quarterly gross profit is $10.00 million
Quarterly EPS-$0.22
PACB quarterly earnings per share is -$0.22

PACB Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$394.24 M
+$6.14 M+1.53%

30 September 2024

1-Year Change

-27.54%
PACB TTM net profit is down -27.54% year-on-year

3-Year Change

-966.7%
PACB TTM net profit is down -966.7% over the past 3 years

All-time High

$29.40 M
PACB TTM net profit is currently -1440.82% below its historical high of $29.40 million

Sector Rank

3.9%
PACB TTM net profit is higher than 3.9% of companies in Healthcare sector
Annual Net Margin-152.97%
PACB annual net profit margin is -152.97%
TTM Revenue$173.15 M
PACB TTM revenue is $173.15 million
TTM Gross Profit$36.80 M
PACB TTM gross profit is $36.80 million
TTM EPS-$1.46
PACB TTM earnings per share is -$1.46

PACB TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PACB Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.4%+9.2%-27.5%
3 y3 years-1143.2%-467.1%-966.7%
5 y5 years-199.1%-108.5%-243.3%

PACB Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1143.2%+2.4%-467.1%+65.0%-966.7%+1.5%
5 y5 years-1143.2%+2.4%-181.0%+65.0%-1440.8%+1.5%
alltimeall time-1143.2%+2.4%-181.0%+65.0%-1440.8%+1.5%

Pacific Biosciences Of California Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$60.73 M(-65.0%)
-$394.24 M(-1.5%)
June 2024
-
-$173.32 M(+121.7%)
-$400.38 M(+34.9%)
Mar 2024
-
-$78.18 M(-4.7%)
-$296.90 M(-3.2%)
Dec 2023
-$306.74 M(-2.4%)
-$82.02 M(+22.7%)
-$306.74 M(-0.8%)
Sept 2023
-
-$66.87 M(-4.2%)
-$309.10 M(-3.2%)
June 2023
-
-$69.83 M(-20.7%)
-$319.20 M(-0.5%)
Mar 2023
-
-$88.02 M(+4.3%)
-$320.76 M(+2.1%)
Dec 2022
-$314.25 M(+73.4%)
-$84.38 M(+9.6%)
-$314.25 M(+5.0%)
Sept 2022
-
-$76.97 M(+7.8%)
-$299.19 M(+45.5%)
June 2022
-
-$71.39 M(-12.4%)
-$205.68 M(+17.3%)
Mar 2022
-
-$81.50 M(+17.6%)
-$175.29 M(-3.3%)
Dec 2021
-$181.22 M(-716.3%)
-$69.33 M(-519.1%)
-$181.22 M(+390.3%)
Sept 2021
-
$16.54 M(-140.3%)
-$36.96 M(-52.1%)
June 2021
-
-$41.00 M(-53.1%)
-$77.21 M(+30.2%)
Mar 2021
-
-$87.44 M(-216.7%)
-$59.29 M(-301.7%)
Dec 2020
$29.40 M(-134.9%)
$74.94 M(-416.1%)
$29.40 M(-164.4%)
Sept 2020
-
-$23.71 M(+2.7%)
-$45.62 M(-10.6%)
June 2020
-
-$23.09 M(-1929.3%)
-$51.04 M(-2.9%)
Mar 2020
-
$1.26 M(-1486.8%)
-$52.55 M(-37.5%)
Dec 2019
-$84.13 M(-18.0%)
-$91.00 K(-99.7%)
-$84.13 M(-26.7%)
Sept 2019
-
-$29.12 M(+18.4%)
-$114.84 M(+3.7%)
June 2019
-
-$24.60 M(-18.9%)
-$110.76 M(+1.9%)
Mar 2019
-
-$30.32 M(-1.5%)
-$108.71 M(+6.0%)
Dec 2018
-$102.56 M(+11.3%)
-$30.80 M(+23.0%)
-$102.56 M(+10.8%)
Sept 2018
-
-$25.04 M(+11.1%)
-$92.53 M(+3.4%)
June 2018
-
-$22.54 M(-6.8%)
-$89.50 M(-3.2%)
Mar 2018
-
-$24.18 M(+16.5%)
-$92.50 M(+0.3%)
Dec 2017
-$92.19 M(+24.0%)
-$20.76 M(-5.7%)
-$92.19 M(+1.9%)
Sept 2017
-
-$22.02 M(-13.8%)
-$90.46 M(+5.3%)
June 2017
-
-$25.54 M(+7.0%)
-$85.93 M(+8.9%)
Mar 2017
-
-$23.87 M(+25.4%)
-$78.89 M(+6.1%)
DateAnnualQuarterlyTTM
Dec 2016
-$74.38 M(+134.7%)
-$19.03 M(+8.8%)
-$74.38 M(+31.0%)
Sept 2016
-
-$17.49 M(-5.4%)
-$56.75 M(+51.6%)
June 2016
-
-$18.50 M(-4.4%)
-$37.44 M(+21.3%)
Mar 2016
-
-$19.35 M(+1273.5%)
-$30.88 M(-2.6%)
Dec 2015
-$31.70 M(-52.1%)
-$1.41 M(-177.4%)
-$31.70 M(-35.7%)
Sept 2015
-
$1.82 M(-115.3%)
-$49.26 M(-18.2%)
June 2015
-
-$11.94 M(-40.8%)
-$60.25 M(-10.7%)
Mar 2015
-
-$20.17 M(+6.3%)
-$67.45 M(+1.9%)
Dec 2014
-$66.16 M(-16.6%)
-$18.98 M(+107.1%)
-$66.16 M(+2.7%)
Sept 2014
-
-$9.16 M(-52.1%)
-$64.42 M(-15.0%)
June 2014
-
-$19.14 M(+1.3%)
-$75.74 M(-1.7%)
Mar 2014
-
-$18.89 M(+9.6%)
-$77.08 M(-2.8%)
Dec 2013
-$79.29 M(-16.1%)
-$17.23 M(-15.9%)
-$79.29 M(-5.3%)
Sept 2013
-
-$20.49 M(+0.1%)
-$83.73 M(-2.6%)
June 2013
-
-$20.47 M(-3.0%)
-$85.97 M(-2.3%)
Mar 2013
-
-$21.10 M(-2.6%)
-$87.99 M(-6.9%)
Dec 2012
-$94.47 M(-13.6%)
-$21.67 M(-4.7%)
-$94.47 M(-1.2%)
Sept 2012
-
-$22.73 M(+1.1%)
-$95.62 M(-6.4%)
June 2012
-
-$22.49 M(-18.5%)
-$102.17 M(+0.0%)
Mar 2012
-
-$27.58 M(+20.8%)
-$102.16 M(-6.6%)
Dec 2011
-$109.39 M(-22.0%)
-$22.82 M(-22.1%)
-$109.39 M(-11.1%)
Sept 2011
-
-$29.28 M(+30.3%)
-$122.98 M(-8.5%)
June 2011
-
-$22.48 M(-35.4%)
-$134.41 M(-7.1%)
Mar 2011
-
-$34.81 M(-4.4%)
-$144.65 M(+3.2%)
Dec 2010
-$140.17 M(+59.8%)
-$36.42 M(-10.5%)
-$140.17 M(+6.3%)
Sept 2010
-
-$40.71 M(+24.4%)
-$131.81 M(+14.0%)
June 2010
-
-$32.71 M(+7.9%)
-$115.63 M(+39.5%)
Mar 2010
-
-$30.32 M(+8.1%)
-$82.92 M(+57.7%)
Dec 2009
-$87.70 M(+100.4%)
-$28.06 M(+14.4%)
-$52.59 M(+114.4%)
Sept 2009
-
-$24.53 M
-$24.53 M
Dec 2008
-$43.75 M(+103.3%)
-
-
Dec 2007
-$21.52 M
-
-

FAQ

  • What is Pacific Biosciences of California annual net profit?
  • What is the all time high annual net income for Pacific Biosciences of California?
  • What is Pacific Biosciences of California annual net income year-on-year change?
  • What is Pacific Biosciences of California quarterly net profit?
  • What is the all time high quarterly net income for Pacific Biosciences of California?
  • What is Pacific Biosciences of California quarterly net income year-on-year change?
  • What is Pacific Biosciences of California TTM net profit?
  • What is the all time high TTM net income for Pacific Biosciences of California?
  • What is Pacific Biosciences of California TTM net income year-on-year change?

What is Pacific Biosciences of California annual net profit?

The current annual net income of PACB is -$306.74 M

What is the all time high annual net income for Pacific Biosciences of California?

Pacific Biosciences of California all-time high annual net profit is $29.40 M

What is Pacific Biosciences of California annual net income year-on-year change?

Over the past year, PACB annual net profit has changed by +$7.51 M (+2.39%)

What is Pacific Biosciences of California quarterly net profit?

The current quarterly net income of PACB is -$60.73 M

What is the all time high quarterly net income for Pacific Biosciences of California?

Pacific Biosciences of California all-time high quarterly net profit is $74.94 M

What is Pacific Biosciences of California quarterly net income year-on-year change?

Over the past year, PACB quarterly net profit has changed by +$6.14 M (+9.19%)

What is Pacific Biosciences of California TTM net profit?

The current TTM net income of PACB is -$394.24 M

What is the all time high TTM net income for Pacific Biosciences of California?

Pacific Biosciences of California all-time high TTM net profit is $29.40 M

What is Pacific Biosciences of California TTM net income year-on-year change?

Over the past year, PACB TTM net profit has changed by -$85.14 M (-27.54%)